Taken together, we revealed that POLE, which is highly expressed in ccRCC tissues, is a promising prognostic biomarker, and it is worthy of further exploration at the transcriptome and proteome levels. This evidence concerns the gene POLE and nonpapillary renal cell carcinoma.